Plasma fluvoxamine levels and OCD symptoms/response in adult patients

about

Pharmacokinetics and pharmacodynamics of psychotropic drugs: effect of sex.Emerging drugs to treat obsessive-compulsive disorder.

P2860

Q38078561-96D7B61F-87C6-4CD3-A704-EB78E9EFB33B Q38174649-EEAC928B-B84F-47DD-809D-9FD7D5B6044C

P2860

Plasma fluvoxamine levels and OCD symptoms/response in adult patients

Item

http://www.wikidata.org/entity/Q57730496

description

article

@en

im Juli 2012 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2012

@uk

name

Plasma fluvoxamine levels and OCD symptoms/response in adult patients

@en

Plasma fluvoxamine levels and OCD symptoms/response in adult patients

@nl

type

Item

label

Plasma fluvoxamine levels and OCD symptoms/response in adult patients

@en

Plasma fluvoxamine levels and OCD symptoms/response in adult patients

@nl

prefLabel

Plasma fluvoxamine levels and OCD symptoms/response in adult patients

@en

Plasma fluvoxamine levels and OCD symptoms/response in adult patients

@nl

P1476

Plasma fluvoxamine levels and OCD symptoms/response in adult patients

@en

P2093

Elisa Schiavi

http://www.w3.org/2001/XMLSchema#string

Gabriele Massimetti

http://www.w3.org/2001/XMLSchema#string

Lionella Palego

http://www.w3.org/2001/XMLSchema#string

Mario Catena-Dell'Osso

http://www.w3.org/2001/XMLSchema#string

Michela Picchetti

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for depression

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance.

Determination of fluvoxamine concentration in plasma by reversed-phase liquid chromatography.

The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders.

Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises?

Controlled-release fluvoxamine in obsessive-compulsive disorder and social phobia.

Treatment strategies for obsessive-compulsive disorder.

Past, present and future drugs for the treatment of obsessive-compulsive disorder.

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.

P304

397-402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HUP.2240

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22806821

http://www.w3.org/2001/XMLSchema#string

Plasma fluvoxamine levels and OCD symptoms/response in adult patients

about

P2860

P2860

Plasma fluvoxamine levels and OCD symptoms/response in adult patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698